SHE: 300583

Insilico Medicine and Seto Biopartner to Leverage AI in Synthetic Biology and Drug Discovery

October 8, 2024

•

Fineline Cube

Insilico Medicine has announced a strategic partnership with Seto Bio (SHE: 300583) to harness cutting-edge AI technology to explore and optimize key steps in the engineering transformation of biological systems, advancing synthetic biology research and innovative drug development. Established in 2014, Insilico Medicine has built over 30 proprietary drug pipeline…
Shandong Saito Biotech to Acquire Majority Stake in Yingu Pharmaceutical

October 16, 2023

•

Fineline Cube

China-based Shandong Saito Bio-Technology Co., Ltd. (SHE: 300583) has announced plans to acquire a 60% stake in fellow Chinese firm Yingu Pharmaceutical Co., Ltd for RMB 458.1 million (USD 62.7 million) in cash. Upon the deal’s closure, Saito will emerge as Yingu’s controlling shareholder, marking a significant strategic move in…

Fineline Info & Tech